RUA Life Sciences (LON:RUA) Issues Earnings Results

RUA Life Sciences (LON:RUA) posted its quarterly earnings results on Tuesday. The company reported GBX (0.33) earnings per share (EPS) for the quarter, Digital Look Earnings reports. The firm had revenue of GBX 275 million for the quarter. RUA Life Sciences had a negative net margin of 3.26% and a negative return on equity of 2.03%.

RUA Life Sciences Stock Up 9.9%

Shares of LON:RUA opened at GBX 19.50 on Tuesday. The stock has a 50-day simple moving average of GBX 19.90 and a 200-day simple moving average of GBX 15.84. The stock has a market capitalization of £12.10 million, a P/E ratio of -2.61 and a beta of 0.96. RUA Life Sciences has a 1 year low of GBX 10.42 and a 1 year high of GBX 26.80. The company has a debt-to-equity ratio of 18.95, a quick ratio of 7.32 and a current ratio of 4.64.

About RUA Life Sciences

The RUA Life Sciences group was created in April 2020 when AorTech International plc acquired RUA Medical Devices Ltd to create a fully formed medical device business. RUA Life Sciences is the holding company of the group trading through four businesses all exploiting the group’s polymer technology. Our vision is to improve the lives of millions of patients by improving and enabling medical devices with Elast-EonTM, the worlds leading long term implantable polyurethane.